Show simple item record

Mycosis fungoides with CD20 expression: report of two cases and review of the literature

dc.contributor.authorHarms, Kelly L.en_US
dc.contributor.authorHarms, Paul W.en_US
dc.contributor.authorAnderson, Thomasen_US
dc.contributor.authorBetz, Bryan L.en_US
dc.contributor.authorRoss, Charles W.en_US
dc.contributor.authorFullen, Douglas R.en_US
dc.contributor.authorHristov, Alexandra C.en_US
dc.date.accessioned2014-06-04T14:57:01Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-06-04T14:57:01Z
dc.date.issued2014-06en_US
dc.identifier.citationHarms, Kelly L.; Harms, Paul W.; Anderson, Thomas; Betz, Bryan L.; Ross, Charles W.; Fullen, Douglas R.; Hristov, Alexandra C. (2014). "Mycosis fungoides with CD20 expression: report of two cases and review of the literature." Journal of Cutaneous Pathology 41(6): 494-503.en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/107359
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCD20en_US
dc.subject.otherLymphomaen_US
dc.subject.otherMycosis Fungoidesen_US
dc.subject.otherCTCLen_US
dc.titleMycosis fungoides with CD20 expression: report of two cases and review of the literatureen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/107359/1/cup12299.pdf
dc.identifier.doi10.1111/cup.12299en_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceMetzman MS, Stevens SR, Griffiths CE, Ross CW, Barnett JM, Cooper KD. A clinical and histologic mycosis fungoides simulant occurring as a T‐cell infiltrate coexisting with B‐cell leukemia cutis. J Am Acad Dermatol 1995; 33: 341.en_US
dc.identifier.citedreferenceSen F, Kang S, Cangiarella J, Kamino H, Hymes K. CD20 positive mycosis fungoides: a case report. J Cutan Pathol 2008; 35: 398.en_US
dc.identifier.citedreferenceBlakolmer K, Vesely M, Kummer JA, Jurecka W, Mannhalter C, Chott A. Immunoreactivity of B‐cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T‐(NK/T‐) cell lymphomas. Mod Pathol 2000; 13: 766.en_US
dc.identifier.citedreferenceMagro CM, Seilstad KH, Porcu P, Morrison CD. Primary CD20+ CD10+ CD8+ T‐cell lymphoma of the skin with IgH and TCR beta gene rearrangement. Am J Clin Pathol 2006; 126: 14.en_US
dc.identifier.citedreferenceSwerdlow SH, Campo E, Harris NL, et al. (eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2008.en_US
dc.identifier.citedreferenceJaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001.en_US
dc.identifier.citedreferenceSong SX, Willemze R, Swerdlow SH, Kinney MC, Said JW. Mycosis fungoides: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013; 139: 466.en_US
dc.identifier.citedreferenceJullie ML, Carlotti M, Vivot A Jr, et al. CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact. Am J Surg Pathol 2013; 37: 1845.en_US
dc.identifier.citedreferenceBenner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 2012; 119: 1643.en_US
dc.identifier.citedreferenceHagen JW, Schaefer JT, Magro CM. CD20+ Mycosis fungoides: a report of three cases and review of the literature. Am J Dermatopathol 2013; 35: 833.en_US
dc.identifier.citedreferenceOlsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713.en_US
dc.identifier.citedreferenceZackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol 2002; 47: 914.en_US
dc.identifier.citedreferenceNoe MH, Drake A, Link BK, Liu V. Papular mycosis fungoides: report of two patients, literature review, and conceptual re‐appraisal. J Cutan Pathol 2013; 40: 714.en_US
dc.identifier.citedreferenceChiang S, DiCaudo DJ, Valdez R, Swanson DL. Cutaneous B‐cell lymphoma with histologic features of mycosis fungoides. J Am Acad Dermatol 2010; 62: 320.en_US
dc.identifier.citedreferenceChui CT, Hoppe RT, Kohler S, Kim YH. Epidermotropic cutaneous B‐cell lymphoma mimicking mycosis fungoides. J Am Acad Dermatol 1999; 41: 271.en_US
dc.identifier.citedreferenceGlusac EJ, Kindel SE, Soslow RA, Smoller BR. Evaluation of classic architectural criteria in non‐mycosis fungoides cutaneous lymphomas. Am J Dermatopathol 1997; 19: 557.en_US
dc.identifier.citedreferencePlaza JA, Kacerovska D, Stockman DL, et al. The histomorphologic spectrum of primary cutaneous diffuse large B‐cell lymphoma: a study of 79 cases. Am J Dermatopathol 2011; 33: 649.en_US
dc.identifier.citedreferenceLanda NG, Zelickson BD, Kurtin PJ, Winkelmann RK. Primary B‐cell lymphoma with histologic features of a T‐cell neoplasm. J Am Acad Dermatol 1992; 26: 288.en_US
dc.identifier.citedreferenceArai E, Shimizu M, Tsuchida T, Izaki S, Ogawa F, Hirose T. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases. Arch Dermatol 2007; 143: 53.en_US
dc.identifier.citedreferenceHultin LE, Hausner MA, Hultin PM, Giorgi JV. CD20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 1993; 14: 196.en_US
dc.identifier.citedreferenceMurayama Y, Mukai R, Sata T, Matsunaga S, Noguchi A, Yoshikawa Y. Transient expression of CD20 antigen (pan B cell marker) in activated lymph node T cells. Microbiol Immunol 1996; 40: 467.en_US
dc.identifier.citedreferenceStein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki‐1 in reactive and neoplastic lymphoid tissue: evidence that Reed‐Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848.en_US
dc.identifier.citedreferenceEdinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH. CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol 2009; 33: 1860.en_US
dc.identifier.citedreferenceHirata Y, Yokote T, Kobayashi K, et al. Rituximab for the treatment of CD20‐positive peripheral T‐cell lymphoma, unspecified. Leuk Res 2009; 33: e13.en_US
dc.identifier.citedreferenceBubien JK, Zhou LJ, Bell PD, Frizzell RA, Tedder TF. Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes. J Cell Biol 1993; 121: 1121.en_US
dc.identifier.citedreferenceMaloney DG. Anti‐CD20 antibody therapy for B‐cell lymphomas. N Engl J Med 2012; 366: 2008.en_US
dc.identifier.citedreferenceMartin B, Stefanato C, Whittaker S, Robson A. Primary cutaneous CD20‐positive T‐cell lymphoma. J Cutan Pathol 2011; 38: 663.en_US
dc.identifier.citedreferenceBalmer NN, Hughey L, Busam KJ, Reddy V, Andea AA. Primary cutaneous peripheral T‐cell lymphoma with aberrant coexpression of CD20: case report and review of the literature. Am J Dermatopathol 2009; 31: 187.en_US
dc.identifier.citedreferenceSun T, Akalin A, Rodacker M, Braun T. CD20 positive T cell lymphoma: is it a real entity? J Clin Pathol 2004; 57: 442.en_US
dc.identifier.citedreferenceRahemtullah A, Longtine JA, Harris NL, et al. CD20+ T‐cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 2008; 32: 1593.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.